Ask Warren

Milae Bioresources

218150 · KOSDAQ · ₩218150 · 미래생명자원

₩1,660▼ ₩27 (1.60%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩19B₩17B₩17B₩19B₩17B₩15B₩14B₩19B
Cost of sales₩17B₩15B₩15B₩15B₩14B₩13B₩12B₩16B
Gross profit₩2.8B₩2.5B₩2.1B₩3.4B₩2.5B₩2.2B₩1.6B₩2.4B
Operating income₩698M₩439M−₩3.3B₩1.2B₩503M₩155M−₩253M₩551M
Net income−₩510M₩537M−₩3.9B₩779M−₩403M₩570M−₩1B₩852M
Net income to shareholders−₩66M₩498M−₩5B₩1.1B₩94M₩528M−₩1.1B₩625M

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩62B₩61B₩59B₩65B₩63B₩64B₩64B₩56B
Current assets₩34B₩33B₩32B₩35B₩33B₩34B₩33B₩42B
Cash and equivalents₩9.6B₩6B₩6.1B₩5.7B₩5.6B₩4B₩4.8B₩16B
Total liabilities₩22B₩18B₩16B₩17B₩17B₩18B₩18B₩11B
Current liabilities₩20B₩16B₩15B₩15B₩15B₩16B₩17B₩11B
Borrowings₩4.9B₩1.5B₩9.1B₩8.5B₩9B₩10B₩11B₩4.8B
Total equity₩40B₩43B₩43B₩48B₩47B₩46B₩46B₩45B
Shareholders' equity₩40B₩41B₩40B₩45B₩44B₩44B₩44B₩45B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations−₩251M−₩492M₩739M₩2.3B₩973M₩383M₩76M₩965M
Capital spending−₩3B₩1.1B₩111M₩29M₩142M₩119M₩36M₩48M
Free cash flow−₩3.2B−₩1.6B₩628M₩2.3B₩831M₩264M₩40M₩917M

Consolidated where available. Amounts in won.

Also known as: Milae Bioresources / 미래생명자원 / 218150 / KRX:218150

Source: KRX statistical information